MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 237 filers reported holding MIRATI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $579 | -83.8% | 13,293 | -86.5% | 0.01% | -79.3% |
| Q2 2023 | $3,567 | -41.4% | 98,738 | -39.7% | 0.03% | -42.0% |
| Q1 2023 | $6,088 | +591.8% | 163,742 | +743.4% | 0.05% | +284.6% |
| Q4 2022 | $880 | -100.0% | 19,414 | -50.7% | 0.01% | -63.9% |
| Q3 2022 | $2,752,000 | -14.0% | 39,402 | +1.2% | 0.04% | -10.0% |
| Q1 2022 | $3,201,000 | +15.6% | 38,927 | +106.2% | 0.04% | +37.9% |
| Q4 2021 | $2,770,000 | -33.3% | 18,881 | -26.6% | 0.03% | -37.0% |
| Q2 2021 | $4,153,000 | +206.7% | 25,713 | +225.4% | 0.05% | +130.0% |
| Q1 2021 | $1,354,000 | -25.6% | 7,902 | -4.7% | 0.02% | +11.1% |
| Q4 2020 | $1,821,000 | -0.7% | 8,293 | -65.2% | 0.02% | -82.2% |
| Q1 2020 | $1,834,000 | – | 23,854 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |